EEF1A1P13

Across TCGA pan-cancer cohorts, EEF1A1P13 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of EEF1A1P13’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where EEF1A1P13 RNA is repressed in tumor relative to normal tissue. In most cancer types EEF1A1P13 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LUSC, KICH, and LIHC are the cancer types where EEF1A1P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EEF1A1P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.687	<.001	8	view →
KICH	Female	II,III,IV	−1.559	<.001	6	view →
LIHC	All	All	+0.366	.003	6	view →
CHOL	All	All	+1.229	.001	5	view →
LUAD	Female	III,IV	−1.226	.007	4	view →
BLCA	All	All	−0.646	.005	4	view →
BRCA	Female	All	−0.526	<.001	4	view →
COAD	All	All	+0.416	.006	4	view →
KIRC	All	All	+0.349	<.001	3	view →
PAAD	Female	All	−1.355	.007	2	view →
UCEC	All	All	−0.820	.006	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

EEF1A1P13–LUSC

Open the LUSC breakdown →